InsiderTrades.com logo
Jim Cramer’s “The Biggest Drug Ever”
From Behind the Markets   |   Ad
This firm's breakthrough has drawn investments from the biggest names in Big Pharma - With companies like Biogen, Sanofi, and Genentech pouring over $1 billion into it.
Unlock the details of this groundbreaking opportunity here...

EPX Insider Trading

Insider Ownership Percentage: 53.87%
Insider Buying (Last 12 Months): A$48,372.03
Insider Selling (Last 12 Months): A$0.00

EP&T Global Insider Trading History Chart

This chart shows the insider buying and selling history at EP&T Global by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

EP&T Global Share Price & Price History

Current Price: A$0.00
Price Change: +0.30 (1.20%)
As of 01/5/2022 11:01 AM ET

This chart shows the closing price history over time for EPX up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Jim Cramer’s “The Biggest Drug Ever”
From Behind the Markets   |   Ad
This firm's breakthrough has drawn investments from the biggest names in Big Pharma - With companies like Biogen, Sanofi, and Genentech pouring over $1 billion into it.
Unlock the details of this groundbreaking opportunity here...

EP&T Global Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/12/2024John BalassisInsiderIssued915,966A$0.02A$18,319.32
11/30/2023John BalassisInsiderIssued5,000,000A$0.02A$110,000.00
9/5/2023John BalassisInsiderBuy800,000A$0.02A$19,200.00
6/30/2023Victor van BommelInsiderBuy884,001A$0.03A$29,172.03
2/8/2023Richard DoyleInsiderIssued2,009,209A$0.03A$50,230.23
12/23/2022Victor van BommelInsiderIssued1,170,920A$0.03A$29,273.00
12/1/2022John BalassisInsiderIssued1,135,211A$0.03A$28,380.28
4/8/2022Keith GunaratneInsiderBuy80,000A$0.13A$10,400.00
3/30/2022John BalassisInsiderBuy150,000A$0.13A$18,750.00
3/15/2022Keith GunaratneInsiderBuy312,521A$0.08A$25,314.20
1/4/2022John BalassisInsiderIssued500,000A$0.15A$75,000.00
See Full Table
Jim Cramer’s “The Biggest Drug Ever”
From Behind the Markets   |   Ad
This firm's breakthrough has drawn investments from the biggest names in Big Pharma - With companies like Biogen, Sanofi, and Genentech pouring over $1 billion into it.
Unlock the details of this groundbreaking opportunity here...

SEC Filings (Institutional Ownership Changes) for EP&T Global (ASX:EPX)

25.27% of EP&T Global stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

EP&T Global Limited provides building energy management solutions to reduce energy and water wastage, and enhance energy efficiency within commercial real estate in Australia, the United Kingdom, Hong Kong, and the Middle East. Its EDGE platform collects, processes, analyses, visualizes, and interprets sets of data for the environmental performance of buildings. The company's solutions cover energy and water analytics, sustainability reporting, building intelligence, demand management, tenant, and health and wellbeing. Its EDGE analytics platform collects data from various processes and sources, such as BMS data, weather, sensors, occupancy, meters, and demand management. The company's services comprise customized reporting, alerts/faults triage, performance reviews, curated action items, power factor correction, engineers on call, and building audits. It serves commercial office, retail, hospitals, schools, hotels, clubs, and industrial sectors. The company was founded in 1993 and is based in North Sydney, Australia.
Read More on EP&T Global

Today's Range

Now: N/A

50 Day Range

MA: N/A

52 Week Range

Now: N/A

Volume

N/A

Average Volume

N/A

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.96

Who are the company insiders with the largest holdings of EP&T Global?

EP&T Global's top insider shareholders include:
  1. John Balassis (Insider)
  2. Richard Doyle (Insider)
  3. Victor van Bommel (Insider)
Learn More about top insider investors at EP&T Global.
Jim Cramer’s “The Biggest Drug Ever”
From Behind the Markets   |   Ad
This firm's breakthrough has drawn investments from the biggest names in Big Pharma - With companies like Biogen, Sanofi, and Genentech pouring over $1 billion into it.
Unlock the details of this groundbreaking opportunity here...